InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+32.3%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Nader Francois, Director. Officer active across 5 companies, notably ALEXION PHARMACEUTICALS, INC.. In total, 12 disclosures have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €344k. Activity tracked since 20 May 2021. The latest transaction was disclosed on 19 July 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations12 total
50,000 shares@ US$3.5250.0% of flowCommon StockSEC:0000899243-22-030924:0
Ideal exit: 15 Apr 2023 (T+270)
50,000 shares@ US$3.5250.0% of flowCommon StockSEC:0000899243-22-026684:0
Ideal exit: 15 Apr 2023 (T+270)
23,100 shares@ US$18.870.0036% mcap100.0% of flowCommon StockSEC:0001127602-22-014263:0
703 shares0Common StockSEC:0001127602-22-012857:0
59,520 shares0Common StockSEC:0000899243-21-048599
59,520 shares0Common StockSEC:0000899243-21-048599:0
6,749 sharesCommon StockSEC:0001104659-21-142272:0
6,749 sharesCommon StockSEC:0001104659-21-142272
13,921 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000065
13,921 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000065:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000043:0
1,962 shares0Common Stock, par value $.0001 per shareSEC:0000899866-21-000043
12 of 12 declarations
About Nader Francois
Francois Nader is a Board Member of ALEXION PHARMACEUTICALS, INC., ACCELERON PHARMA INC, and Talaris Therapeutics, Inc. He plays a key role in the governance of these companies and brings his expertise in strategy and business development.
